Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Topiramate linked to birth defects: FDA
FDA has asked healthcare professionals to warn patients of childbearing age about the potential hazard to the foetus if a woman becomes pregnant while taking the drug. Data
FDA has asked healthcare professionals to warn patients of childbearing age about the potential hazard to the foetus if a woman becomes pregnant while taking the drug. Data
In the study, Tofacitinib showed changes versus placebo in reducing signs and symptoms of RA; in improving physical function; and in reaching DAS28-4(ESR) <2.6 at six months. The
The investigational compound Clobazam, is marketed under the brand names Frisium and Urbanol, is a drug which is a benzodiazepine derivative. Lundbeck announced Onfi as the proposed US
The new 14,500sqft Clinical Trial Supply Depot offers secured controlled drug, -2 to 8C cold storage, -20C frozen and -80C deep frozen storage facility. Further, the company’s clinical
China Shengda Packaging provides paper packaging solutions to a wide variety of industries, including food, beverage, cigarette, household appliance, consumer electronics, pharmaceuticals, chemicals, machinery and other consumer and
Gambro is 49% owned by Investor AB and remaining by EQT IV. Terumo will use available cash and bank loans to complete the deal, which is expected to
Aptiv Solutions provides drug development consulting and regulatory services essential to progress a development program from research to product approval. Ricerca CEO Ian Lennox said the Fulcrum Pharma
The agreement allows Amyris to own and distribute the produced products under the collaboration. Amyris and Antibioticos commenced test fermentation runs in January 2011, and, based on the
Proteonomix is a biotechnology company engaged in developing therapeutics based upon the use of human cells and their derivatives. Proteonomix further intends to use THOR BioPharma to serve
The co-primary endpoints will be progression-free survival and overall survival and the company expects to commence this Phase 3 clinical trial of Folotyn in 2011. Allos chief medical